Erik joined Julius Clinical in January 2019. His primary driver is to get new therapies to patients, through impeccable service delivery to clients.

For nearly 20 years, he has supported pharmaceutical and biotech companies in (early phase) drug development. Both at large and small size CROs and in project management, business development and general management roles.

At PRA Health Sciences he served in the Management Team for the clinical pharmacology units in The Netherlands, being responsible for global Business Development and subsequently for all CRO services. As the VP of Clinical Research at NIZO Food Research, he successfully reorganized their clinical research unit and installed a GCP compliant QMS.

Erik holds a PharmD from the University of Groningen, The Netherlands.